2017 an increase of 22% EBITDA: 54mTHB in Q4 2018 compared to 37mTHB in Q4 2017 an increase of 46%; 2018 full year 230mTHB compared to 172mTHB in 2017 an increase of 34% Net income: 25mTHB in Q4 2018
follows: Early Warning Score Program (EWS): Program to warn and aware to protect Septicemia. Linkage system of other medial with Anesthesia Record System which is in under phase II which the Company
medical devices and equipment business, expanding the existing customer base and new customers and increase new products such as Early Warning Score Program (EWS): Program to warn and aware to protect
and subsidiaries reported Baht 9,744 million in net profit, decreasing Baht 1,173 million or 10.75 percent over-quarter. The decrease could be attributed to non-interest income, which dropped Baht 3,187
under the Innovation Development Program to Support Provision of Capital Market Services [regulatory sandbox]. “fee” means a fee for undertaking business according to license; “Exchange” means the Stock
under the Innovation Development Program to Support Provision of Capital Market Services [regulatory sandbox]. “ fee ” means a fee for undertaking business according to license; “ Exchange ” means the
2018 in the relevant matters: (1) the regulator of the foreign service provider is located in a country that has participated in the Financial Sector Assessment Program (FSAP) and received the assessment
relevant matters: (1) the regulator of the foreign service provider is located in a country that has participated in the Financial Sector Assessment Program (FSAP) and received the assessment results not
continued to grow well by c.20%. Net profit in Q2/2017 was Baht 61 million, a decrease of 57% YoY due to 1) higher cost per unit resulted from lower capacity utilization; 2) higher depreciation resulted